Steatohepatitic hepatocellular carcinoma

Abstract

Subtypes of hepatocellular carcinoma are important for 2 primary reasons: they help improve diagnostic accuracy, as different subtypes have their own diagnostic pitfalls; they are an important building block to the personalization of patient care, as subtypes are enriched for shared genetic changes and biological associations. The most common subtype of hepatocellular carcinoma is steatohepatitic hepatocellular carcinoma (SH-HCC), a subtype that is strongly linked to tumorigenesis in the setting of the metabolic syndrome and metabolic-associated liver disease (MAFLD) and/or alcoholic hepatitis. SH-HCC shows macrovesicular steatosis, balloon cells, Mallory hyaline, intratumoral inflammation, and intratumoral fibrosis. This review examines the historical development of this subtype and explores in detail the histological features that are used to define SH-HCC. The strongest molecular correlates to-date include a low frequency of CTNNB1 mutations and possible activation of the IL6/JAK/STAT pathway. In addition, critical unresolved questions are discussed in detail to refine the histological definition of SH-HCC, including the minimal histological thresholds needed to make the diagnosis, as well as whether or not SH-HCC currently is a mixed category of tumors, containing some tumors where the distinctive morphology is driven by tumor-specific genetic changes, and other tumors where the findings are an epiphenomenon, a reflection of metabolic or alcohol-associated fatty liver disease, and not necessarily of genetic/epigenetic changes.

Keywords

Hepatocellular carcinoma / steatohepatitic / steatohepatitis / steatosis

References

[1] Torbenson MS.Morphologic subtypes of hepatocellular carcinoma.Gastroenterol Clin North Am2017;46:365-91

[2] Torbenson MS,Yeh MM. Tumors of the liver. : Washington, DC: American Registry of Pathology; 2018. p. 449.

[3] Edmondson HA. Tumors of the liver and intrahepatic bile ducts. Washington DC: Armed Forces Institute of Pathology; 1958.

[4] Salomao M,Brown RS Jr,Lefkowitch JH.Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.Am J Surg Pathol2010;34:1630-6

[5] Salomao M,Vaughan R,Lefkowitch JH.The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis.Hum Pathol2012;43:737-46

[6] Jain D,Kumaran V.Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India.Arch Pathol Lab Med2013;137:961-6

[7] Shibahara J,Sakamoto Y,Fukayama M.Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients.Histopathology2014;64:951-62

[8] Chan AW,Yu YH.Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse.Histopathology2016;69:971-84

[9] Taniai M,Tobari M.Clinicopathological investigation of steatohepatitic hepatocellular carcinoma: A multicenter study using immunohistochemical analysis of adenoma-related markers.Hepatol Res2018;48:947-55

[10] Yeh MM,Torbenson M.Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study.Hum Pathol2015;46:1769-75

[11] Qin J,Nakagawa S.Steatohepatitic variant of hepatocellular carcinoma is associated with both alcoholic steatohepatitis and nonalcoholic steatohepatitis: A study of 2 cohorts with molecular insights.Am J Surg Pathol2020;44:1406-12 PMCID:PMC7942811

[12] Aigelsreiter A,Pichler M.Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis.Liver Int2017;37:600-10

[13] Inui S,Tanahashi Y.Steatohepatitic hepatocellular carcinoma: imaging findings with clinicopathological correlation.Clin Radiol2021;76:160.e15- e25

[14] Hatano M,Masugi Y.Steatotic and nonsteatotic scirrhous hepatocellular carcinomas reveal distinct clinicopathological features.Hum Pathol2019;86:222-32

[15] de Campos PB,Stefano JT.Hepatocellular carcinoma in non-alcoholic fatty liver disease (NAFLD) - pathological evidence for a predominance of steatohepatitic inflammatory non-proliferative subtype.Histol Histopathol2020;35:729-40

[16] Tan PS,Goossens N.Clinicopathological indices to predict hepatocellular carcinoma molecular classification.Liver Int2016;36:108-18 PMCID:PMC4674393

[17] Ando S,Hayashi A.Beta-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study.Virchows Arch2015;467:535-42

[18] Calderaro J,Imbeaud S.Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.J Hepatol2017;67:727-38

[19] Shin JH,Jeon EJ,Shin HJ.Overexpression of C-reactive protein as a poor prognostic marker of resectable hepatocellular carcinomas.J Pathol Transl Med2015;49:105-11 PMCID:PMC4367105

[20] Deniz K,Yeh MM.Steatohepatitis-like changes in focal nodular hyperplasia, a finding to distinguish from steatohepatitic variant of hepatocellular carcinoma.Am J Surg Pathol2017;41:277-81

[21] Liu Y,Yeh MM.Steatohepatitis-like changes in hepatocellular adenoma.Am J Clin Pathol2020;154:525-32

[22] Wood LD,Daniel HD.Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features.Mod Pathol2013;26:1586-93 PMCID:PMC3974906

[23] Terada T,Hoso M,Sasaki M.Fatty macroregenerative nodule in non-steatotic liver cirrhosis. A morphologic study.Virchows Arch A Pathol Anat Histopathol1989;415:131-6

[24] Kutami R,Nakashima O,Kojiro M.Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans.J Hepatol2000;33:282-9

[25] Friemel J,Frick L.Intratumor heterogeneity in hepatocellular carcinoma.Clin Cancer Res2015;21:1951-61